Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Shengshi Longfang Pharmaceutical is a pharmaceutical company based in Douyun, Guizhou, China. It develops and manufactures both herbal medicines and small molecule/chemical drugs. The company has at least five approved products targeting infectious diseases, nervous system diseases, neoplasms, immune system diseases, and endocrinology/metabolic disease. Notable marketed drugs include ShanHuXuanJing for tinea manus (fungal infection), JinWuGuTong for osteoporosis, and YinDanXinTai for angina pectoris[4]. No detailed clinical trial results are publicly available.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Shengshi Longfang Pharmaceutical.